Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
825.45
+4.41 (0.54%)
At close: Oct 24, 2025, 4:00 PM EDT
825.55
+0.10 (0.01%)
After-hours: Oct 24, 2025, 7:59 PM EDT
Eli Lilly Market Cap
Eli Lilly has a market cap or net worth of $741.04 billion as of October 24, 2025. Its market cap has decreased by -15.23% in one year.
Market Cap
741.04B
Enterprise Value
777.05B
1-Year Change
-15.23%
Ranking
Category
Stock Price
$825.45
Market Cap Chart
Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $741.04B, an increase of 646.65%. That is a compound annual growth rate of 7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 781.25B | 6.60% |
| Dec 31, 2024 | 732.87B | 32.44% |
| Dec 29, 2023 | 553.37B | 59.19% |
| Dec 30, 2022 | 347.61B | 31.56% |
| Dec 31, 2021 | 264.23B | 63.60% |
| Dec 31, 2020 | 161.51B | 27.99% |
| Dec 31, 2019 | 126.19B | 2.94% |
| Dec 31, 2018 | 122.58B | 31.81% |
| Dec 29, 2017 | 93.00B | 14.54% |
| Dec 30, 2016 | 81.20B | -13.04% |
| Dec 31, 2015 | 93.37B | 21.55% |
| Dec 31, 2014 | 76.82B | 33.69% |
| Dec 31, 2013 | 57.46B | 0.39% |
| Dec 31, 2012 | 57.23B | 18.95% |
| Dec 30, 2011 | 48.12B | 19.08% |
| Dec 31, 2010 | 40.41B | -1.52% |
| Dec 31, 2009 | 41.03B | -10.38% |
| Dec 31, 2008 | 45.79B | -24.40% |
| Dec 31, 2007 | 60.56B | 2.72% |
| Dec 29, 2006 | 58.96B | -8.34% |
| Dec 30, 2005 | 64.32B | 0.16% |
| Dec 31, 2004 | 64.22B | -18.68% |
| Dec 31, 2003 | 78.97B | 10.71% |
| Dec 31, 2002 | 71.33B | -19.21% |
| Dec 31, 2001 | 88.30B | -15.83% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |
| Merck & Co. | 218.53B |